These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 35949163)

  • 1. Sodium-glucose cotransporter-2 inhibitor-induced euglycemic diabetic ketoacidosis: A case report.
    Han J; Xie S; Jiao H
    J Clin Pharm Ther; 2022 Sep; 47(9):1482-1485. PubMed ID: 35949163
    [No Abstract]   [Full Text] [Related]  

  • 2. Euglycemic Ketoacidosis With Sodium-Glucose Cotransporter-2 Inhibitor.
    Koch RA; Clark RF
    Am J Ther; 2018; 25(5):e590-e591. PubMed ID: 28452848
    [No Abstract]   [Full Text] [Related]  

  • 3. Sodium-glucose cotransporter 2 inhibitor-induced euglycemic diabetic ketoacidosis in a patient with coronavirus disease 2019: a case report.
    Yii ESS; Azli AW; Sitaram PN
    J Med Case Rep; 2022 Jan; 16(1):17. PubMed ID: 34983625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Euglycemic Diabetic Ketoacidosis Associated With SGLT2 Inhibitor Therapy: A Case Report.
    Klinkner G; Steingraber-Pharr M
    AACN Adv Crit Care; 2023 Mar; 34(1):27-32. PubMed ID: 36877649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Euglycemic diabetic ketoacidosis associated with the use of a sodium-glucose cotransporter-2 inhibitor.
    Zhang L; Tamilia M
    CMAJ; 2018 Jun; 190(25):E766-E768. PubMed ID: 29941433
    [No Abstract]   [Full Text] [Related]  

  • 6. Sodium-glucose cotransporter-2-induced euglycemic diabetic ketoacidosis unmasks latent autoimmune diabetes in a patient misdiagnosed with type 2 diabetes mellitus: a case report.
    Vadasz B; Arazi M; Shukha Y; Koren O; Taher R
    J Med Case Rep; 2021 Feb; 15(1):62. PubMed ID: 33581735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Euglycemic diabetic ketoacidosis in type 2 diabetes treated with a sodium-glucose cotransporter-2 inhibitor.
    Jazi M; Porfiris G
    Can Fam Physician; 2016 Sep; 62(9):722-4. PubMed ID: 27629667
    [No Abstract]   [Full Text] [Related]  

  • 8. Sodium-glucose cotransporter type 2 inhibitors: managing the small but critical risk of diabetic ketoacidosis.
    Hamblin PS; Wong R; Bach LA
    Med J Aust; 2020 Apr; 212(7):294-296.e1. PubMed ID: 32124975
    [No Abstract]   [Full Text] [Related]  

  • 9. Ketoacidosis Due to Empagliflozin, a Paradigm Shift: Case Report and Review of Literature.
    Hernandez-Quiles C; Ramirez-Duque N; Acosta-Delgado D
    Curr Diabetes Rev; 2019; 15(4):259-262. PubMed ID: 30047331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intraoperative Diagnosis of Sodium-Glucose Cotransporter 2 Inhibitor-Associated Euglycemic Diabetic Ketoacidosis: A Case Report.
    Seger CD; Xing H; Wang L; Shin JS
    A A Pract; 2021 Jan; 15(1):e01380. PubMed ID: 33512907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two cases of euglycemic diabetic ketoacidosis after bariatric surgery associated with sodium-glucose cotransporter-2 inhibitor use.
    Amianda EA; Gavigan TS; Talishinskiy T; Ewing DR; Schmidt HJ
    Obes Surg; 2021 Aug; 31(8):3848-3850. PubMed ID: 33895974
    [No Abstract]   [Full Text] [Related]  

  • 12. Euglycemic diabetic ketoacidosis associated with sodium-glucose cotransporter type 2 inhibitors.
    Isern de Val Í; Mercado Castillo H; Díaz Melé MDC
    Med Clin (Barc); 2024 Jul; 163(2):101-102. PubMed ID: 38677916
    [No Abstract]   [Full Text] [Related]  

  • 13. Empagliflozin-Associated Euglycemic Diabtetic Ketoacidosis.
    Soni P; Kumar V; Saradna A; Kupfer Y
    Am J Ther; 2018; 25(6):e740-e741. PubMed ID: 29746292
    [No Abstract]   [Full Text] [Related]  

  • 14. Protracted glycosuria after discontinuation of sodium-glucose cotransporter 2 inhibitors: Implications for weekly dosing and extended risk of euglycemic diabetes ketoacidosis.
    Alhassan S; Rudoni M; Alfonso-Jaume MA; Jaume JC
    J Diabetes; 2019 May; 11(5):410-411. PubMed ID: 30552748
    [No Abstract]   [Full Text] [Related]  

  • 15. [Diabetic euglycemic ketosis or ketoacidosis in individuals with type 2 diabetes treated by SGLT2 inhibitors: A series of Belgian clinical cases].
    Menghoum N; Oriot P; Hermans MP; Mariage JL
    Rev Med Interne; 2020 Apr; 41(4):226-231. PubMed ID: 31866073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diabetic ketoacidosis with sodium-glucose cotransporter type 2 inhibitors: a case series.
    McLachlan G; Keith C; Frauman A
    Med J Aust; 2019 Sep; 211(5):237-237.e1. PubMed ID: 31420875
    [No Abstract]   [Full Text] [Related]  

  • 17. Diabetic ketoacidosis in patients under treatment with sodium-glucose cotransporter type 2 inhibitors.
    López Medina JA; Hernández García C; Espíldora Hernández J
    Med Clin (Barc); 2017 Oct; 149(7):311-312. PubMed ID: 28662890
    [No Abstract]   [Full Text] [Related]  

  • 18. SGLT2 Inhibitors and Euglycemic Ketoacidosis.
    Masuta P; Johri G; Paul M
    Am J Ther; 2018; 25(4):e498-e500. PubMed ID: 28537992
    [No Abstract]   [Full Text] [Related]  

  • 19. Sodium-Glucose Cotransporter-2 Inhibitors Increase Risk of Diabetic Ketoacidosis in Adults With Type 2 Diabetes: Should We Be Concerned in People Without Diabetes?
    Goldenberg RM
    Can J Diabetes; 2022 Mar; 46(2):109. PubMed ID: 35283060
    [No Abstract]   [Full Text] [Related]  

  • 20. Euglycemic diabetic ketoacidosis in a patient on sodium-glucose cotransporter 2 inhibitors.
    Hammond DB; Ingram CC
    JAAPA; 2023 Sep; 36(9):1-3. PubMed ID: 37668485
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.